PCBP4
Basic information
Region (hg38): 3:51957454-51974016
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCBP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 1 | 0 |
Variants in PCBP4
This is a list of pathogenic ClinVar variants found in the PCBP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-51958108-C-T | not specified | Uncertain significance (Jun 14, 2023) | ||
3-51958125-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
3-51958140-C-G | not specified | Uncertain significance (Jun 16, 2024) | ||
3-51958159-A-C | Likely benign (May 31, 2018) | |||
3-51958195-G-A | not specified | Uncertain significance (May 26, 2024) | ||
3-51958228-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
3-51958234-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
3-51958258-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
3-51958806-A-G | not specified | Uncertain significance (Nov 17, 2022) | ||
3-51958808-T-A | not specified | Uncertain significance (Sep 17, 2021) | ||
3-51958869-C-T | not specified | Uncertain significance (Jun 19, 2024) | ||
3-51958937-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
3-51959261-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
3-51959291-A-C | not specified | Uncertain significance (Jan 19, 2024) | ||
3-51959391-C-A | not specified | Uncertain significance (Nov 15, 2021) | ||
3-51959908-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
3-51959959-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
3-51960269-T-C | not specified | Uncertain significance (Dec 14, 2023) | ||
3-51960279-C-G | not specified | Uncertain significance (Jun 11, 2021) | ||
3-51960290-T-C | not specified | Uncertain significance (Oct 05, 2023) | ||
3-51960582-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
3-51960599-C-T | not specified | Uncertain significance (May 15, 2024) | ||
3-51960606-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
3-51960626-G-T | not specified | Uncertain significance (Oct 17, 2023) | ||
3-51961179-C-T | not specified | Uncertain significance (Oct 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PCBP4 | protein_coding | protein_coding | ENST00000461554 | 12 | 10957 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00237 | 0.995 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.65 | 175 | 248 | 0.705 | 0.0000154 | 2543 |
Missense in Polyphen | 71 | 118.35 | 0.59991 | 1162 | ||
Synonymous | 0.0551 | 108 | 109 | 0.993 | 0.00000738 | 901 |
Loss of Function | 2.58 | 8 | 20.7 | 0.387 | 0.00000114 | 223 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000119 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000191 | 0.000185 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000362 | 0.000359 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. {ECO:0000250}.;
- Pathway
- TP53 Regulates Transcription of Cell Cycle Genes;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional activation of cell cycle inhibitor p21 ;Transcriptional activation of p53 responsive genes ;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;TP53 Regulates Transcription of Cell Cycle Genes;Transcriptional Regulation by TP53;Direct p53 effectors;Cell Cycle
(Consensus)
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.728
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.77
Haploinsufficiency Scores
- pHI
- 0.282
- hipred
- N
- hipred_score
- 0.403
- ghis
- 0.513
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.756
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pcbp4
- Phenotype
- renal/urinary system phenotype; respiratory system phenotype; neoplasm; cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;regulation of mRNA stability
- Cellular component
- cytosol
- Molecular function
- DNA binding;RNA binding;mRNA 3'-UTR binding